Skip to content

Prognosis of HIV/HCV-coinfected patients may be better than previously thought

Predicting which HIV/HCV-coinfected patients will respond to HCV treatment: some expected and some surprising answers

Anti-HIV treatment may mean that progression of hepatitis C no worse in coinfected patients than in those with only hepatitis C

Ribavirin levels after four weeks of treatment predict which HIV/hepatitis C coinfected and re-treated patients will respond

HIV-positive gay men and sexual transmission of hepatitis C: it's no longer just northern Europe

HIV and hepatitis coinfection in Africa: studies provide conflicting prevalence data

Around 10% of HIV-positive patients without hepatitis B virus or hepatitis C virus found to have signs of liver damage

First-line antiretroviral therapy: not as simple as we'd like it to be

Insulin resistance means coinfected patients have a poorer response to hepatitis C treatment